Edition:
United Kingdom

Kitov Pharma Ltd (KTOV.OQ)

KTOV.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
23 Feb 2018
Change (% chg)

$0.06 (+2.28%)
Prev Close
$2.63
Open
$2.68
Day's High
$2.69
Day's Low
$2.60
Volume
4,327
Avg. Vol
49,491
52-wk High
$3.41
52-wk Low
$1.27

Chart for

About

Kitov Pharma Ltd, formerly Kitov Pharmaceuticals Holdings Ltd, is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Kitov pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package

* Kitov Pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package

01 Nov 2017

BRIEF-Kitov Pharmaceuticals announces phase III/IV clinical trial for KIT-302 successfully meets primary endpoint

* Kitov pharmaceuticals announces phase iii/iv clinical trial for kit-302 successfully meets primary endpoint, and also demonstrates drug candidate improves renal function

26 Oct 2017

BRIEF-Kitov boosts ownership in Tyrnovo and Oncology platform

* Kitov boosts ownership in Tyrnovo and Oncology platform through exchange of shares for stock

06 Oct 2017

BRIEF-Kitov posts filing by FDA of New Drug Application for KIT-302

* Kitov announces filing by FDA of New Drug Application for KIT-302

02 Oct 2017

Earnings vs. Estimates